Evidence map›Paper›PMID 24146860›Full record

ArticlePloS one2013

A polyclonal antibody based immunoassay detects seven subtypes of Shiga toxin 2 produced by Escherichia coli in human and environmental samples.

Xiaohua He, Stephanie Patfield, Robert Hnasko, Reuven Rasooly, Robert E Mandrell

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Validation of a Cell-Based Assay for Detection of Active Shiga Toxins Produced byInternational journal of environmental research and public health · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A review on detection methods used for foodborne pathogens.The Indian journal of medical research · 2016
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Salmonella, Shigella, and yersinia.Clinics in laboratory medicine · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Xiaohua HeWestern Regional Research Center, Agricultural Research Service, United States Department of Agriculture (USDA), Albany, California, United States of America.
Stephanie Patfield
Robert Hnasko
Reuven Rasooly
Robert E Mandrell
Agricultural Research Service · USUnited States Department of Agriculture · USWestern Regional Research Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundShiga toxin-producing Escherichia coli (STEC) are frequent causes of severe human diseases ranging from diarrhea to hemolytic uremic syndrome. The existing strategy for detection of STEC relies on the unique sorbitol-negative fermentation property of the O157 strains, the most commonly identified serotype has been E. coli O157. It is becoming increasingly evident, however, that numerous non-O157 STEC serotypes also cause outbreaks and severe illnesses. It is necessary to have new methods that are capable of detecting all STEC strains. METHODS AND

findingsHere we describe the development of a sandwich ELISA assay for detecting both O157 and non-O157 STECs by incorporating a novel polyclonal antibody (pAb) against Stx2. The newly established immunoassay was capable of detecting Stx2a spiked in environmental samples with a limit of detection between 10 and 100 pg/mL in soil and between 100 and 500 pg/mL in feces. When applied to 36 bacterial strains isolated from human and environmental samples, this assay detected Stx2 in all strains that were confirmed to be stx2-positive by real-time PCR, demonstrating a 100% sensitivity and specificity.

conclusionsThe sandwich ELISA developed in this study will enable any competent laboratory to identify and characterize Stx2-producing O157 and non-O157 strains in human and environmental samples, resulting in rapid diagnosis and patient care. The results of epitope mapping from this study will be useful for further development of a peptide-based antibody and vaccine.

Indexed as

Environmental MicrobiologyAnimalsAntibodies, BacterialAntibody SpecificityAntigens, BacterialChlorocebus aethiopsEnzyme-Linked Immunosorbent AssayEpitope MappingHumansImmune SeraImmunizationImmunoassayImmunoglobulin GNeutralization TestsShiga-Toxigenic Escherichia coliShiga Toxin 2Antibodies, BacterialAntigens, BacterialImmune SeraImmunoglobulin GShiga Toxin 2

Identifiers

PMID24146860
PMCPMC3797811
OpenAlexW2023645250

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.